Number of respondents by (selected*) first cancer site and date of diagnosis: Medicare Advantage

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 56,142 21,333 38.00 8,465 15.08 8,063 14.36 10,908 19.43 7,373 13.13
Breast 55,079 22,900 41.58 7,069 12.83 6,547 11.89 8,884 16.13 9,679 17.57
Lung and Bronchus 34,688 28,204 81.31 3,287 9.48 1,412 4.07 1,109 3.20 676 1.95
Colorectal 32,995 18,027 54.64 4,017 12.17 3,223 9.77 3,978 12.06 3,750 11.37
Melanoma Skin 18,009 9,324 51.77 2,177 12.09 1,991 11.06 2,264 12.57 2,253 12.51
Bladder 17,385 10,320 59.36 2,127 12.23 1,659 9.54 1,794 10.32 1,485 8.54
Non-Hodgkins Lymphoma 12,145 7,430 61.18 1,431 11.78 1,115 9.18 1,216 10.01 953 7.85
Uterine Corpus 9,501 3,830 40.31 1,110 11.68 1,085 11.42 1,449 15.25 2,027 21.33
Kidney/Renal Pelvis 8,956 5,117 57.13 1,146 12.80 968 10.81 1,006 11.23 719 8.03
Head/Neck 8,085 4,304 53.23 1,087 13.44 789 9.76 996 12.32 909 11.24
Leukemia 7,529 5,004 66.46 996 13.23 560 7.44 619 8.22 350 4.65
Pancreas 7,100 6,467 91.08 415 5.85 109 1.54 75 1.06 34 0.48
Stomach 4,293 3,125 72.79 494 11.51 229 5.33 254 5.92 191 4.45
Liver/Bile Duct 3,764 3,122 82.94 359 9.54 140 3.72 99 2.63 44 1.17
Ovary 3,388 2,086 61.57 405 11.95 249 7.35 260 7.67 388 11.45
Esophagus 2,304 1,834 79.60 216 9.38 114 4.95 98 4.25 42 1.82
Uterine Cervix 1,271 467 36.74 108 8.50 116 9.13 180 14.16 400 31.47

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 23 Feb, 2023